FAM
PACB icon

Fred Alger Management’s Pacific Biosciences PACB Stock Holding History

Fred Alger Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-62,105
Closed -$609K – 483
2023
Q4 		$609K Buy
+62,105
New +$508K ﹤0.01% 384
2023
Q3 		– Sell
-69,780
Closed -$928K – 511
2023
Q2 		$928K Buy
+69,780
New +$848K ﹤0.01% 380
2018
Q4 		– Sell
-180,000
Closed -$974K – 558
2018
Q3 		$974K Buy
+180,000
New +$772K ﹤0.01% 324
2016
Q4 		– Sell
-10,000
Closed -$90K – 510
2016
Q3 		$90K Buy
+10,000
New +$83.6K ﹤0.01% 384

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return